Basic Research
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 28, 2005; 11(24): 3701-3709
Published online Jun 28, 2005. doi: 10.3748/wjg.v11.i24.3701
Figure 1
Figure 1 Serum ALT (A) and TNFα (B) levels in mice after treatment with GalN, LPS, anti-TNFα IgG, GalN/LPS. bP <0.01 vs GalN, LPS and anti-TNFα IgG groups.
Figure 2
Figure 2 Liver injury stained with hematoxylin-eosin. A: NS-treated group 100×; B: LPS-treated group 400×; C: GalN-treated group 400×; D: GalN/LPS-treated group100×; E: GalN/TNFα-treated group 100×; F: anti-TNFα IgG-treated group 100×.
Figure 3
Figure 3 Morphology of large (A-F) and small (a-f) intestinal samples stained with hematoxylin-eosin; A, a: NS-treated group; B, b: LPS-treated group; C, c: GalN-treated group; D, d: GalN/ LPS-treated group; E, e: GalN/TNFα IgG-treated group; F, f: anti-TNFα-treated group.
Figure 4
Figure 4 Structure of apoptotic enterocytes with transmission electron microscopy.
Figure 5
Figure 5 Morphology of enterocyte apoptosis in large (A-F) and small (a-f) intestine.
Figure 6
Figure 6 Enterocyte apoptosis rate of mice at different time points after GalN/LPS injection. A: large intestinal tissues. B: small intestinal tissues bP <0.01 vs other time points in the same group.
Figure 7
Figure 7 Changes of TNFR1 protein expression.
Figure 8
Figure 8 IOD level of TNFR1 in mice at different time points after GalN/LPS treatment. A: large intestinal tissues. B: small intestinal tissues. aP<0.05; bP <0.01 vs 2 h time point.